KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Non Operating Income (2018 - 2025)

Vir Biotechnology's Non Operating Income history spans 8 years, with the latest figure at -$335000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 100.51% year-over-year to -$335000.0; the TTM value through Dec 2025 reached -$409000.0, down 100.49%, while the annual FY2025 figure was -$409000.0, 100.64% down from the prior year.
  • Non Operating Income for Q4 2025 was -$335000.0 at Vir Biotechnology, down from -$228000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $138.3 million in Q4 2021 and bottomed at -$91.9 million in Q1 2022.
  • The 5-year median for Non Operating Income is $204500.0 (2023), against an average of $10.8 million.
  • The largest YoY upside for Non Operating Income was 35475.0% in 2022 against a maximum downside of 811.73% in 2022.
  • A 5-year view of Non Operating Income shows it stood at $138.3 million in 2021, then crashed by 40.78% to $81.9 million in 2022, then plummeted by 133.72% to -$27.6 million in 2023, then skyrocketed by 338.15% to $65.8 million in 2024, then plummeted by 100.51% to -$335000.0 in 2025.
  • Per Business Quant, the three most recent readings for VIR's Non Operating Income are -$335000.0 (Q4 2025), -$228000.0 (Q3 2025), and $226000.0 (Q2 2025).